CD73-adenosine reduces immune responses and survival in ovarian cancer patients

DOI: 10.1080/2162402X.2015.1127496

Keywords: A2A, adenosine, CD39, CD73, immune checkpoint, immunotherapy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text